サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1754324

人工肺の市場規模、シェア、動向、予測：タイプ、年齢層、用途、地域別、2025-2033年

Oxygenators Market Size, Share, Trends and Forecast by Type, Age Group, Application, and Region, 2025-2033

出版日
発行
IMARC
ページ情報
英文 140 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.80円
人工肺の市場規模、シェア、動向、予測：タイプ、年齢層、用途、地域別、2025-2033年
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

人工肺の世界市場規模は2024年に2億7,190万米ドルとなりました。今後、IMARC Groupは、市場は2033年までに4億1,952万米ドルに達し、2025年から2033年にかけて4.94％のCAGRを示すと予測しています。現在、北米が市場を独占しており、2024年の市場シェアは45.3%を超えています。同市場は、心血管疾患や呼吸器疾患の有病率の高さ、外科手術の増加、同地域の強力なヘルスケアインフラの進歩によって牽引されています。

世界の人工肺市場は、世界の心血管疾患と呼吸器疾患の有病率の増加によって牽引されています。世界保健機関（WHO）によると、30～70歳の心血管疾患（CVDs）、がん、糖尿病、慢性呼吸器疾患の死亡リスクは18％です。このため、クリティカルケアや外科手術における人工肺の需要が高まり、市場の成長を後押ししています。さらに、医療技術の進歩が人工肺の効率と安全性を向上させ、採用率を押し上げ、市場の需要を促進しています。このほか、慢性的な健康状態が酸素補給を必要とするため、老年人口が増加していることも市場拡大に寄与しています。また、外科手術、特に開心術の増加も市場の成長を促しています。さらに、新興国におけるヘルスケアインフラの拡大が先進医療機器へのアクセスを強化し、市場成長の触媒となっています。

米国の人工肺市場は83.20％の市場シェアを占めています。同地域の需要は、心血管疾患や肺疾患の有病率の高さが原動力となっています。これに伴い、高齢者は酸素補給を必要とする慢性疾患にかかりやすいため、高齢化も大きく寄与しています。また、同国はヘルスケアシステムが発達しているため、最先端技術へのアクセスが広く確保されており、市場開拓を促進しています。同時に、心臓手術や体外膜酸素療法（ECMO）の件数が増加していることも、市場に弾みをつけています。これとは別に、人工肺の継続的な技術進歩が効率性と安全性を高め、採用を後押しして市場を前進させています。

人工肺市場の動向：

心臓病の有病率の増加

世界中で人工肺の需要が増加している主な原因は、心臓病の患者です。2024年1月に英国心臓財団（British Heart Foundation）が発表した調査によると、心臓および循環器系疾患を患う患者はアジアだけで約6億4,000万人にのぼる。患者数は着実に増加しており、酸素供給技術の応用や心臓手術用機器の強化が求められるようになると思われます。人工肺市場は、心臓治療の改善に世界の注目が集まり続けていることから、大きな成長が見込まれています。心臓病の罹患率の増加、医療技術の進歩に伴い、酸素供給プロセスを必要とする手術における革新的なソリューションに対する需要が高まり、その結果、この市場は全体的に成長します。

老年人口の増加

65歳以上の人口は、2021年の7億6,100万人から2050年には16億人へと2倍以上に増加し、80歳以上の人口はさらに急速に増加するとみられます。国連によると、人口動態の変化は、心血管障害や呼吸器障害といった加齢に関連した疾患が非常に高い割合で増加していることを示しており、そのほとんどが高度な酸素供給ソリューションを必要としています。したがって、ヘルスケアに対する需要の増大が人工肺をクリティカルケア分野に押しやり、人工肺の市場を拡大しています。高齢化に伴い、ヘルスケアシステムはいくつかの課題に直面することになります。そのため、人工肺は、高齢者の治療や介護が向上するにつれて、まもなく需要が増加すると思われます。

戦略的イノベーションと統合システム

市場プレーヤーは、消費者からの需要の高まりに対応するため、特に人工肺を統合したシステムの改良を通じて、戦略的なイノベーションを行っています。2024年4月に発売されたLivaNova Essenz灌流システムは、このラインにおける重要なリリースのひとつです。このシステムは、成人および小児の開心術患者用に設計されており、手術の効率性と安全性をより達成しやすくするために、いくつかの主要な要素が組み合わされています。このシステムには、先進的なメンブレン人工肺やその他の重要な要素が統合されており、包括的な心臓ケアソリューションへのシフトという業界の特徴となっています。手技の結果を改善する一方で、技術革新は医療機器の洗練性と機能性の新たな基準を確立することで、世界の人工肺市場の成長にも大きく貢献しています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の人工肺市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 膜型人工肺
  • 気泡型人工肺

第7章 市場内訳：年齢層別

  • 新生児
  • 子供
  • 大人

第8章 市場内訳：用途別

  • 呼吸器
  • 心臓
  • 体外心肺
  • 蘇生（ECPR）

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Braile Biomedica
    • Chalice Medical Ltd
    • Eurosets S.r.l.
    • Getinge AB
    • Livanova Plc
    • Medtronic plc
    • MicroPort
    • Nipro Corporation
    • Senko Medical Instrument Mfg. Co. Ltd.
    • Terumo Medical Corporation（Terumo Corporation）
    • Xenios AG（Fresenius Medical Care AG & Co. KGaA）
図表

List of Figures

  • Figure 1: Global: Oxygenators Market: Major Drivers and Challenges
  • Figure 2: Global: Oxygenators Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Oxygenators Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Oxygenators Market: Breakup by Age Group (in %), 2024
  • Figure 6: Global: Oxygenators Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Oxygenators Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Oxygenators (Membrane Oxygenator) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Oxygenators (Membrane Oxygenator) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Oxygenators (Bubble Oxygenator) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Oxygenators (Bubble Oxygenator) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Oxygenators (Neonates) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Oxygenators (Neonates) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Oxygenators (Pediatric) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Oxygenators (Pediatric) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Oxygenators (Adults) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Oxygenators (Adults) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Oxygenators (Respiratory) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Oxygenators (Respiratory) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Oxygenators (Cardiac) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Oxygenators (Cardiac) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Oxygenators (Extracorporeal Cardiopulmonary) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Oxygenators (Extracorporeal Cardiopulmonary) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Oxygenators (Resuscitation-ECPR) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Oxygenators (Resuscitation-ECPR) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia-Pacific: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia-Pacific: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Oxygenators Market: Breakup by Country (in %), 2024
  • Figure 74: Middle East and Africa: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Global: Oxygenators Industry: SWOT Analysis
  • Figure 76: Global: Oxygenators Industry: Value Chain Analysis
  • Figure 77: Global: Oxygenators Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oxygenators Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Oxygenators Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Oxygenators Market Forecast: Breakup by Age Group (in Million USD), 2025-2033
  • Table 4: Global: Oxygenators Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Oxygenators Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Oxygenators Market: Competitive Structure
  • Table 7: Global: Oxygenators Market: Key Players
目次
Product Code: SR112025A6448

The global oxygenator market size was valued at USD 271.9 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 419.52 Million by 2033, exhibiting a CAGR of 4.94% from 2025-2033. North America currently dominates the market, holding a market share of over 45.3% in 2024. The market is driven by the high prevalence of cardiovascular and respiratory diseases, increasing surgical procedures, and strong healthcare infrastructure advancements in the region.

The global oxygenator market is driven by the growing prevalence of cardiovascular and respiratory diseases worldwide. According to the World Health Organization (WHO), the mortality risk for cardiovascular disease (CVDs), cancer, diabetes, or chronic respiratory disease between the ages of 30 and 70 is 18%. This has increased the demand for oxygenators in critical care and surgeries, aiding the market growth. Moreover, ongoing advancements in medical technology have improved oxygenator efficiency and safety, boosting adoption rates, and fueling the market demand. Besides this, the rising geriatric populations are contributing to the market expansion, as chronic health conditions require oxygenation support. Also, the increasing number of surgical procedures, especially open-heart surgeries is impelling the market growth. Furthermore, the expanding healthcare infrastructure in emerging economies enhances access to advanced medical devices, catalyzing the market growth.

The United States oxygenator market holds a market share of 83.20%. The demand in the region is driven by a high prevalence of cardiovascular and pulmonary diseases. In line with this, the aging population contributes significantly, as elderly individuals are more susceptible to chronic conditions requiring oxygenation support. Also, the country's well-developed healthcare system ensures widespread access to cutting-edge technologies, fostering the market growth. Concurrently, the increased numbers of cardiac surgeries and extracorporeal membrane oxygenation (ECMO) procedures, are providing an impetus to the market. Apart from this, continuous technological advancements in oxygenators enhance efficiency and safety, boosting adoption and propelling the market forward.

Oxygenators Market Trends:

Growing Prevalence of Heart Disease

Heart disease cases represent the main cause of the increased demand for oxygenators throughout the globe. Research published by the British Heart Foundation in January 2024 has found that some 640 million people suffering from heart and circulatory diseases reside in Asia alone. With a steadily increased number of patients, patients will demand the application of oxygenation technology and enhanced cardiac surgery devices. The oxygenators market is expected to grow massively with continued global attention being focused on improving cardiac care. With the increase in the incidence of heart diseasebi, along with advances in medical technologies, there's a demand for innovative solutions in surgeries that require the oxygenation process, resulting in overall growth in this market.

Rising Geriatric Population

The number of people aged 65 and older will more than double, from 761 million in 2021 to 1.6 billion by 2050, and the population aged 80 and above is likely to grow even faster. According to the United Nations, demographic shifts indicate that age-related conditions such as cardiovascular and respiratory disorders are increasing at a very high rate, most of which demand advanced oxygenation solutions. Hence, the increased demand for healthcare is pushing oxygenators into critical care areas and increasing the markets for oxygenators. With the aging population, healthcare systems are destined to face several challenges. Thus, oxygenators are likely to see a rise in demand shortly as the elderly are treated and cared for better.

Strategic Innovations and Integrated Systems

Market players are making strategic innovations to keep up with the growing demand from consumers, especially through improving systems that integrate oxygenators. One of the key releases in this line is the LivaNova Essenz Perfusion System which hit the market in April 2024. It is designed for both adults and pediatric open-heart surgery patients, combining several main elements to make surgical efficiency and safety more achievable. The system integrates advanced membrane oxygenators and other critical elements, which have become a hallmark of the industry's shift toward comprehensive cardiac care solutions. While improving procedural outcomes, innovations are also significantly contributing to the growth of the global oxygenators market by establishing new benchmarks in medical device sophistication and functionality.

Oxygenators Industry Segmentation:

Analysis by Type:

  • Membrane Oxygenator
  • Bubble Oxygenator

Membrane oxygenators dominate the oxygenator segment because of their high performance and versatility in various clinical settings and operations. The growth of this segment is further attributed to the growing incidence of cardiovascular and respiratory diseases which necessitate extracorporeal oxygenation support. Additionally, the development of new membranes has enhanced the efficiency of the gas exchange and increased the durability and biocompatibility of the membrane, which is increasing the uptake of the equipment. High incidences of cardiac and pulmonary procedures such as open heart procedures are major drivers of increased demand. Another factor is the increasing population of geriatric patients who are more susceptible to chronic diseases and thus require oxygenators. Moreover, the growing use of extracorporeal membrane oxygenation or ECMO therapy in the critical care segment contributes to the segment's visibility. Furthermore, pressures towards patient safety and clinical outcomes have made people prefer membrane oxygenators to bubble oxygenators, to ensure they gain more market standards.

Analysis by Age Group:

  • Neonates
  • Pediatric
  • Adults

The neonate segment in the oxygenator market is driven by the increasing prevalence of congenital heart defects and respiratory complications in newborns. Specialized oxygenators designed for delicate physiology ensure precise gas exchange and temperature control, essential for neonatal care. Growing neonatal intensive care units (NICUs) and advancements in pediatric cardiac surgery further bolster demand for neonatal oxygenators, driving the market forward.

The pediatric segment is growing due to increasing incidences of congenital heart diseases and respiratory diseases among children. Pediatric oxygenators are designed to suit the sizes and metabolic requirements of children. Moreover, ongoing technological enhancements in pediatric surgical procedures and ECMO therapies along with rising awareness of early management of chronic ailments are providing an impetus to the market.

The adult segment dominates due to the high incidence of cardiovascular diseases, respiratory failures, and surgeries requiring oxygenation support. Aging populations and lifestyle-related conditions like obesity and smoking increase demand. Advanced oxygenator technologies enhance safety and efficiency in adult surgeries while expanding critical care and ECMO usage for severe respiratory conditions further fueling the market growth.

Analysis by Application:

  • Respiratory
  • Cardiac
  • Extracorporeal Cardiopulmonary
  • Resuscitation (ECPR)

Respiratory leads the market with a share of 59.3%. This segment dominates the oxygenator market, driven by the increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and pneumonia. In addition, the rising pollution levels and smoking rates exacerbate respiratory health issues, boosting the demand for oxygenators. The segment also benefits from the growing adoption of ECMO therapy for severe respiratory failure. Moreover, continuous advancements in oxygenator technology, including improved biocompatibility and gas exchange efficiency, enhance their suitability for long-term respiratory support. Concurrently, the aging population is more prone to chronic respiratory conditions, which is another critical growth factor. Apart from this, the expanding healthcare infrastructure and critical care capabilities in emerging markets are boosting the adoption of oxygenators in respiratory care and increasing awareness of advanced respiratory therapies.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America dominates the oxygenator market with a share of 45.3%. The demand in this segment is driven by advanced healthcare infrastructure and the high prevalence of cardiovascular and respiratory diseases. The aging population of the region is significantly contributing to the market growth, as elderly individuals are more prone to conditions requiring oxygenation support. Moreover, the increasing adoption of ECMO therapy in critical care settings further fuels demand. The region also benefits from robust R&D activities, leading to continuous advancements in oxygenator technologies that enhance efficiency, safety, and biocompatibility. The high volume of surgical procedures, particularly cardiac and pulmonary surgeries, boosts the utilization of oxygenators. Besides this, favorable reimbursement policies and increasing healthcare expenditure support widespread adoption, thereby impelling the market growth.

Key Regional Takeaways:

United States Oxygenators Market Analysis

The rising prevalence of chronic obstructive pulmonary disease, which is the third leading cause of death in the U.S. aside from cancer and heart conditions, is one of the biggest factors in oxygenators uptake. The American Lung Association says that 11 million people are diagnosed with COPD in the country yearly, thus the more urgent need for respiratory-based health care. This trend is expected to increase the demand for membrane oxygenators, which are widely used in ECMO devices to provide life support to patients with severe cardiopulmonary diseases. Membrane oxygenators are advanced over the traditional bubble oxygenators. They offer features such as better platelet functioning, higher platelet count, and reduced hemolysis during perfusion. These features enhance patient outcomes while making them more attractive in critical care. Demand for advanced respiratory support devices is on the rise which will expand the use of membrane oxygenators and augment the growth of the market for oxygenators in the U.S.

Europe Oxygenators Market Analysis

The significant burden of circulatory system diseases on healthcare systems and government budgets will drive the Europe oxygenators market. According to an industrial report, there were 1.71 million deaths in the EU because of diseases in the circulatory system in 2021, representing 32.4% of all deaths. That trend is expected to be maintained, thus boosting the demand for oxygenators to treat patients with disorders of the circulatory system. Such higher prevalence in the region's areas of coronary artery disease, heart failure, and pulmonary embolism will contribute more to market growth. It is the increasing adoption of minimally invasive surgical procedures and the incidence of respiratory disease that adds to demand and growth. European healthcare is shifting toward the oxygenation of advanced therapy methods to further improve the chances of improved patient outcomes through reduced cost of healthcare and other preventive measures. As a result, the Europe oxygenators market is expected to see remarkable growth, with the prominent players investing in research and development to innovate and further improve oxygenator technology. This trend is likely to continue as the demand for effective and efficient oxygenation therapies increases.

Asia Pacific Oxygenators Market Analysis

The significant burden of circulatory system diseases on healthcare systems and government budgets will drive the Asia Pacific oxygenators market. India forms a fifth of the total deaths due to coronary heart disease worldwide, and deaths due to CHD are up by 100% since 1990, as per industrial reports. It is estimated to further increase by 50% by 2030. In addition, the contribution of the region in curbing major diseases, such as that of South Korea donating USD 4 million to Indonesia in 2021, further fuels the market for oxygenators. The increasing adoption of minimally invasive surgical procedures and the rising incidence of respiratory diseases will also drive demand. As the Asian healthcare sector shifts towards advanced oxygenation therapies to improve patient outcomes and reduce healthcare costs, the demand for effective and efficient oxygenation therapies is expected to increase. The Asia Pacific oxygenators market is expected to witness remarkable growth as the key players in the market invest in research and development for innovation and improvement in oxygenator technology.

Latin America Oxygenators Market Analysis

The burden of chronic respiratory diseases in Latin America will drive the Latin America oxygenators market. Chronic obstructive pulmonary disease (COPD) and tuberculosis are leading causes of morbidity and mortality in Brazil. In addition, smoking is a key factor in the growth of the respiratory devices market; 9.1% of the population aged 15+ years smokes daily, according to OECD statistics for 2021. Significant tobacco use will increase the risk of developing respiratory diseases such as asthma and COPD. Growth in the increasing rates of tuberculosis in Brazil according to the WHO Global Tuberculosis Report, dated 2022, further fuels the market. The incidence of tuberculosis in Brazil stood at 48 per 100,000 people in 2021. In turn, a high prevalence of smoking and tuberculosis is expected to propel the Latin America oxygenators market across the forecast period, wherein the demand for effective and efficient oxygenation therapies rises to enhance patient outcomes as well as reduce healthcare costs.

Middle East and Africa Oxygenators Market Analysis

The Middle East and Africa oxygenators market will be propelled by the high incidence burden of asthma in this region. For instance, asthma has a severe burden in countries like Uganda with mortality 90 times greater than that found in the United Kingdom. A study by the Journal of the Pan African Thoracic Society (JPATS) showed that only 33% of asthma patients in Uganda had the disease in control, pointing out the lack of awareness about monitoring and the severity of the disease. The adoption of cost-effective solutions such as pulse oximeters for respiratory monitoring will spur the growth of the market. As the healthcare sector in the region shifts toward advancing technologies to improve patient outcomes and reduce healthcare costs, the demand for effective and efficient oxygenation therapies is expected to increase. Additionally, the rising prevalence of respiratory diseases and increased awareness of asthma management will also drive demand for oxygenators in the Middle East and Africa.

Competitive Landscape:

The competitive landscape of the oxygenator market is characterized by intense innovation and strategic activities among key players. Companies are heavily investing in research and development (R&D) to enhance oxygenator efficiency, biocompatibility, and safety. Mergers, acquisitions, and collaborations are common strategies to expand product portfolios and market presence. Major trends include the integration of advanced materials and the development of portable and lightweight oxygenators for improved usability. Moreover, regulatory approvals for novel products further drive competition. Also, the increasing focus on ECMO systems and personalized solutions tailored to patient needs is shaping market dynamics. Additionally, partnerships with healthcare providers and institutions strengthen distribution networks, enhancing players' competitive edge.

The report provides a comprehensive analysis of the competitive landscape in the oxygenator market with detailed profiles of all major companies, including:

  • Braile Biomedica
  • Chalice Medical Ltd
  • Eurosets S.r.l.
  • Getinge AB
  • Livanova Plc
  • Medtronic plc
  • MicroPort
  • Nipro Corporation
  • Senko Medical Instrument Mfg. Co. Ltd.
  • Terumo Medical Corporation (Terumo Corporation)
  • Xenios AG (Fresenius Medical Care AG & Co. KGaA)

Key Questions Answered in This Report

  • 1.What is oxygenator?
  • 2.How big is the global oxygenator market?
  • 3.What is the expected growth rate of the global oxygenator market during 2025-2033?
  • 4.What are the key factors driving the global oxygenator market?
  • 5.What is the leading segment of the global oxygenator market based on type?
  • 6.What is the leading segment of the global oxygenator market based on application?
  • 7.What are the key regions in the global oxygenator market?
  • 8.Who are the key players/companies in the global oxygenator market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oxygenators Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Membrane Oxygenator
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Bubble Oxygenator
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Age Group

  • 7.1 Neonates
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pediatric
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Adults
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Respiratory
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cardiac
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Extracorporeal Cardiopulmonary
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Resuscitation (ECPR)
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Braile Biomedica
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Chalice Medical Ltd
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Eurosets S.r.l.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Getinge AB
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Livanova Plc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Medtronic plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 MicroPort
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Nipro Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Senko Medical Instrument Mfg. Co. Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Terumo Medical Corporation (Terumo Corporation)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Xenios AG (Fresenius Medical Care AG & Co. KGaA)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio